Mice carrying the MLL-PTD mutation show developmental abnormalities and dysregulated Hox gene expression similar to AML patients with the MLL-PTD mutation (47), but require additional leukemogenic driver mutations such as the Flt3-internal tandem duplication (48) for overt leukemogenesis. This evidence concerns the gene FLT3 and acute myeloid leukemia.